✦ LIBER ✦

Risk factors for symptomatic hypocalcaemia complicating treatment with zoledronic acid

✍ Scribed by S. Chennuru; J. Koduri; M. A. Baumann

Book ID: 109003230
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 83 KB
Volume: 38
Category: Article
ISSN: 1444-0903
DOI: 10.1111/j.1445-5994.2007.01580.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment Persistence With Monthly Zoled

Treatment Persistence With Monthly Zoledronic Acid is Associated With Lower Risk and Frequency of Skeletal Complications in Patients With Breast Cancer and Bone Metastasis

✍ Hind T. Hatoum; Swu-Jane Lin; Matthew R. Smith; Amy Guo; Allan Lipton 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 374 KB

Intravenous Zoledronic Acid to Prevent O

Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy

✍ Bhoopalam, Nirmala; Campbell, Steven C.; Moritz, Thomas; Broderick, William R.; 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 762 KB

P107 Zoledronic acid is superior to pami

P107 Zoledronic acid is superior to pamidronate in patients with breast cancer and multiple myeloma who are at high risk for skeletal complications

✍ M. Kaminski; L. Rosen; D. Gordon; M. Zheng; Y. Hei 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 162 KB

CO4 A COMPARISON OF LOGISTIC REGRESSION

CO4 A COMPARISON OF LOGISTIC REGRESSION AND COX PROPORTIONAL HAZARDS MODELS FOR IDENTIFICATION OF RISK FACTORS FOR RENAL IMPAIRMENT IN HORMONE REFRACTORY PROSTATE CANCER (HRPC) PATIENTS WITH BONE METASTASES (BM) TREATED WITH ZOLEDRONIC ACID (ZA)

✍ WK Oh; K Proctor; M Nakabayashi; C Evan; LK Tormey; L Breierova; M Smith; M Near 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

1305 POSITIVE ANTI-GP210 ANTIBODIES IS A

1305 POSITIVE ANTI-GP210 ANTIBODIES IS A RISK FACTOR FOR POOR BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT IN JAPANESE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS

✍ Nakamura, M.; Ito, M.; Yamamoto, K.; Zeniya, M.; Ohira, H.; Hashimoto, E.; Honda 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB